High expression of immunotherapy candidate proteins gp100, MART-1, tyrosinase and TRP-1 in uveal melanoma.

por de Vries, T. J., Trancikova, D., Ruiter, D. J., van Muijen, G. N.
Publicado 1998

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.

por van den Ingh, H. F., Ruiter, D. J., Griffioen, G., van Muijen, G. N., Ferrone, S.
Publicado 1987

Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals.

por Nelemans, P J, Groenendal, H, Kiemeney, L A, Rampen, F H, Ruiter, D J, Verbeek, A L
Publicado 1993

Melanoma-inhibiting activity (MIA) mRNA is not exclusively transcribed in melanoma cells: low levels of MIA mRNA are present in various cell types and in peripheral blood

por Vries, T J de, Fourkour, A, Punt, C J A, Diepstra, H, Ruiter, D J, Muijen, G N P van
Publicado 1999

No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisited.

por Mooy, C. M., Van der Helm, M. J., Van der Kwast, T. H., De Jong, P. T., Ruiter, D. J., Zwarthoff, E. C.
Publicado 1991

Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.

por Nooijen, P. T., Manusama, E. R., Eggermont, A. M., Schalkwijk, L., Stavast, J., Marquet, R. L., de Waal, R. M., Ruiter, D. J.
Publicado 1996

Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays

por de Wit, N J W, Rijntjes, J, Diepstra, J H S, van Kuppevelt, T H, Weidle, U H, Ruiter, D J, van Muijen, G N P
Publicado 2005

Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression

por Hofmann, U B, Westphal, J R, Waas, E T, Zendman, A J W, Cornelissen, I M H A, Ruiter, D J, Muijen, G N P van
Publicado 1999

Radiological imaging of teratological fetuses: what can we learn?

por Boer, Lucas L., Schepens-Franke, A. N., van Asten, J. J. A., Bosboom, D. G. H., Kamphuis-van Ulzen, K., Kozicz, T. L., Ruiter, D. J., Oostra, R-J., Klein, W. M.
Publicado 2017

Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue

por Ferrier, C M, Witte, H H de, Straatman, H, Tienoven, D H van, Geloof, W L van, Rietveld, F J R, Sweep, C G J, Ruiter, D J, Muijen, G N P van
Publicado 1999

Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential.

por Westphal, J. R., van't Hullenaar, R. G., van der Laak, J. A., Cornelissen, I. M., Schalkwijk, L. J., van Muijen, G. N., Wesseling, P., de Wilde, P. C., Ruiter, D. J., de Waal, R. M.
Publicado 1997

High tPA-expression in primary melanoma of the limb correlates with good prognosis

por Ferrier, C M, Suciu, S, van Geloof, W L, Straatman, H, Eggermont, A M M, Koops, H Schraffordt, Kroon, B B R, Lejeune, F J, Kleeberg, U R, van Muijen, G N P, Ruiter, D J
Publicado 2000

Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR

por de Vries, T J, Fourkour, A, Punt, C J A, van de Locht, L T F, Wobbes, T, Bosch, S van den, Rooij, M J M de, Mensink, E J B M, Ruiter, D J, Muijen, G N P van
Publicado 1999